OncoSec Medical Inc (ONCSQ)

[hschlauch]

Not a bad article. You know, there is one thing that continues to bug me about the company - they essentially have no pipeline. Any prospective investor looking at this company takes a quick glance at their product pipeline and sees essentially nothing - there are no new listed gene products other than the IL-12 combination in melanoma. What happens if the PISCES trial data aren't as good as hoped? Why take the risk if that is all they got?

Now I realize they are actively pursuing multigene constructs, but they STILL have not announced what the next product(s) would be; it has been all general information about possible combinations, nothing concrete. No investor wants to take the risk if they have no real pipeline. They need to solidify these other products.